Philadelphia Chromosome Positive Recruiting Phase 3 Trials for Cefotaxime (DB00493)

Also known as: Philadelphia chromosome positive

IndicationStatusPhase
DBCOND0046287 (Philadelphia Chromosome Positive)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs